Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of HL301 in acute bronchitis
NCT02250027Phase 2Completed
- Sponsor
- Hanlim Pharm
- Start
- Mar 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HL301 in acute bronchitis, chronic bronchitis (CB), sponsored by Hanlim Pharm. Started Mar 2014; status: completed.
02
Drugs
HL301
03
Conditions
acute bronchitischronic bronchitis (CB)
Beyond the preview
Go deeper on NCT02250027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02250027.